Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Malaysian stocks start week on positive note

23h theedgemarkets
KUALA LUMPUR (Aug 20): Malaysian stocks started the week on a positive note, as selected heavyweight counters like Petronas Chemicals Group Bhd, Axiata Group Bhd and DiGi.Com Bhd lifted the benchmark FBM KLCI up 4.11 points or 0.23% despite negative market breadth.
6084 5183 6888 PECGF 1899 UPBMF 5032 AXXTF 2836 2089

0
KLCI rises 0.39%, inches closer to 1,800 mark

2018-08-08 theedgemarkets
KUALA LUMPUR (Aug 8): The FBM KLCI rose 0.39% at the midday break today, as gains in select index-linked blue chips lifted it closer to the 1,800-point mark, tracking the advance at regional markets.
5198 7113 5032 6432 TPGVF BATS 4162 7765 0096 7043 5168 5014 TGLVY 5029 5225 3301 MYPRY Q0F IHHHF HRGHY

0
KLCI reverses loss but broader sentiment stays tepid

2018-07-31 theedgemarkets
KUALA LUMPUR (July 31): The FBM KLCI reversed its earlier losses at the midday break today, lifted by select index-linked blue chips, but the broader market sentiment remained tepid, tracking regional markets.
7083 HLFBF 1082 5032 NFLX BATS 4162 3794 9334 6033 7277 2852 PNADF 5225 3301 3867 4723 Q0F IHHHF 6807 PNAGF 1929

15
KLCI down 0.38% as regional markets turn choppy

2018-06-12 theedgemarkets
KUALA LUMPUR (June 12): The FBM KLCI fell 0.38% at the midday break today against the backdrop of choppy regional markets, dragged by select index-linked blue chips.
HLFBF 7251 MLYBY MLYNF UPBMF 1082 7113 5032 8664 TPGVF BATS 4162 2089 9334 2852 TGLVY 1155 0047 5347 3301 TNABY TNABF GEBHF

11
KLCI remains under pressure as select blue chips weigh

2018-06-12 theedgemarkets
KUALA LUMPUR (June 12): The FBM KLCI remained under pressure at mid-morning today, dragged by select index-linked blue chips.
HLFBF 7251 UPBMF 1082 7113 5032 TPGVF BATS 4162 7153 5168 2089 9334 TGLVY 5139 0047 5347 3026 0104 0900 6645 TNABY TNABF HRGHY

0
Trading ideas: Luxchem, Lotte Chemical, Yinson, Censof, Bintulu Port

2018-05-02 thestar.com.my
KUALA LUMPUR: Luxchem Corp Bhd , Lotte Chemical Titan Holding Bhd, Yinson Holdings Bhd , Censof Holdings Bhd and Bintulu Port Holdings Bhd are among the stocks to watch on Wednesday, according to JF Apex Research.
7293 7206 5032 5195

0
Supply base to be built in Bintulu for O&G industry

2018-04-20 thestar.com.my
It’s a deal: Johari (second from right) and OBYU Holdings Sdn Bhd founder and advisor Tan Sri Bustari Yusof witnessing the exchange of documents between Ahmadi (left) and Hadzari.
5032

0
Bintulu Port eyes provision of bunkering services

2018-04-01 thestar.com.my
KUCHING: Bintulu Port Holdings Bhd (BPHB) plans to diversify into providing bunkering services at Bintulu Port for commercial vessels. The company has the Samalaju Industrial Port on the South China sea.
5032

0
Minister among those dropped from PRS’ list of candidates in Sarawak

2018-03-30 themalaymailonline
Entulu has represented Selangau since 2004. — Foto ehsan Facebook/Joseph Entulu BelaunKUCHING, March 30 ― Parti Rakyat Sarawak (PRS) deputy president Datuk Joseph Entulu Belaun will not be fielded to defend his Selangau parliamentary seat in the upcoming general election, party president Tan Sri Dr James Masing said today.
5032

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...